﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical and Biological Research</journalTitle>
    <eissn>2328-4099</eissn>
    <publicationDate>2014-05-27</publicationDate>
    <volume>2</volume>
    <issue>3</issue>
    <startPage>76</startPage>
    <endPage>82</endPage>
    <doi>10.12691/ajmbr-2-3-2</doi>
    <publisherRecordId>AJMBR2014232</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Association of Adipocytokines: Resistin and Retinol Binding Protein-4 with Severity of Preeclampsia and Insulin Resistance</title>
    <authors>
      <author>
        <name>Abeer A. EL-Refai</name>
        <affiliationId>1</affiliationId>
        <affiliationId>2</affiliationId>
      </author>
      <author>
        <name>Sameer H. Fatani</name>
        <affiliationId>2</affiliationId>
      </author>
      <author>
        <name>Hala F. M. Kamel</name>
        <email>kamelhala@msn.com</email>
        <affiliationId>2</affiliationId>
        <affiliationId>3</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Biochemistry Department, Faculty of medicine, Umm Al-Qura University (UQU), Makkha, KSA</affiliationName>
    </affiliationsList>
    <abstract language="eng">Dysregulation of maternal circulating adipocytokines has been implicated in several obstetrical syndromes including preeclampsia (PE). It has been suggested that adipocytokines provide a molecular link between metabolic derangements and inflammatory response in complicated pregnancies. We aimed in this study to evaluate the relationship between serum levels of Retinol binding protein-4 (RBP-4) and Resistin with clinical, anthropometric and metabolic parameters of PE. This study included 3 groups: group 1 included 50 pregnant females with PE, group 2 included 50 healthy pregnant females and group 3 included 50 healthy non-pregnant female as a control group. For all groups anthropometric and clinical measurements were performed. Serum RBP-4, resistin, insulin were measured by ELISA and Insulin resistance was calculated by Hemostasis model assessment index (HOMA-IR). Our results showed that serum RBP-4 and resistin concentrations were elevated in PE [39(33.25-40.87) ug/ml] &amp; [61(23.5-91.87) ng/ml] compared to normal pregnancy [18.5(8-27.87) ug/ml] &amp; [25.5(12.7-49.12) ng/ml). Moreover, RBP4 but not resistin levels were elevated in severe cases relative to mild cases of PE. Serum levels of RBP4 showed positive significant correlation with [SBP (r=0.38, p= 0.001) &amp; DBP (r=0.32, p=0.01)] which are markers of severity. Fasting insulin was positively correlated with RBP-4 (p=0.04). By multiple linear regression analysis, serum RBP-4 levels were significantly and positively correlated with SBP (P=0.01), while markers of adiposity were not independently associated with resistin. Conclusion: RBP-4 and resistin were up-regulated in PE, furthermore RBP-4 not resistin levels were independently associated with markers of severity of PE. However no clear relationship were observed between HOMA-IR with both RBP-4 and resistin and the role of Insulin resistance in PE was not clearly proved.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmbr/2/3/2/ajmbr-2-3-2.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>preeclampsia</keyword>
      <keyword>Resistin</keyword>
      <keyword>Retinol binding protein-4</keyword>
      <keyword>HOMA-IR</keyword>
    </keywords>
  </record>
</records>